Rong (@_RongL) header
Rong (@_RongL) profile picture

Senior Editor at @NatureBiotech. Views are my own

London, England
Joined January 2019
Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors go.nature.com/4atBJML
2
23
100
13,733
The dawn of in vivo immune cell engineering in oncology go.nature.com/4r732m4
1
13
58
5,709
On our latest podcast, Barbara Cheifet talks with Zhenan Bao and John Rogers about the latest in electronic wearables and how they will complement and advance global health — from health monitoring in neonates to smart bandages for wounds shows.acast.com/forum/episod…
2
8
3,527
🚨New podcast alert🚨 On the latest episode of Forum, Barbara Cheifet speaks with Vasilis Ntziachristos and Junjie Yao about how photoacoustic imaging is moving towards translational applications such as diagnostics and disease monitoring shows.acast.com/forum/episod…
1
3
16
4,410
With this cross-journal Collection, the editors at @CommsEng, @NatureBiotech, @NatureComms & @SciReports invite manuscripts that highlight continual or real-time sensing systems of any form, primarily for arable farming or crop production. Submission deadline: 21 January 2026 nature.com/collections/hdhad…
1
4
7
4,295
Fruit waste for catwalk fashion nature.com/articles/s41587-0…
2
2
3,769
The May issue is live nature.com/nbt/volumes/43/is… On the cover, a platform for template-independent enzymatic synthesis of RNA oligonucleotides using reversible terminator nucleoside triphosphates that offers a sustainable alternative to traditional methods go.nature.com/3zBfDZf
28
1
95
17,104
Synergizing advances in artificial intelligence with mathematical modeling will improve our ability to computationally predict immunotherapy outcomes go.nature.com/4jfqM3Y rdcu.be/eh1qR
10
26
1
78
8,043
The identification of novel targets together with technological advances is transforming our ability to effectively modulate the tumor microenvironment go.nature.com/42Bo9lT rdcu.be/eiiow
4
28
78
7,720
The April issue is live, with a focus on cancer immunotherapy nature.com/nbt/volumes/43/is… On the cover, recent clinical trials and patient reports have found promising outcomes of locoregional administration of CAR T cells across different solid tumors go.nature.com/3Z4eBiQ
3
22
3
103
15,569
Spotlight on cancer immunotherapies go.nature.com/3XUTPkM
10
1
36
6,217
A method for designing high-affinity, specific binders to peptide–MHC complexes may improve the next generation of antigen-specific T cell-based therapeutics #NBTNV go.nature.com/3ZFVH0O rdcu.be/d3ZBW
5
37
2
160
18,812
Plant bling: cellulose that sparkles nature.com/articles/s41587-0…
1
1
1
10
3,811
In Brief: One year after partnering with Zhuhai, China–based Biotheus on a bispecific antibody targeting PD-L1 and VEGF-A, @BioNTech_Group acquires the company for up to $950 million nature.com/articles/s41587-0…
4
10
3,913
Our editors pick their favorite research articles from 2024 go.nature.com/49kVEvC
6
1
35
5,890
Our top ten news stories in 2024 nature.com/articles/s41587-0…
1
5
14
4,250
The @NobelPrize in medicine was awarded for the discovery of miRNA, but miRNA therapeutics have a long way to go before they outcompete other therapies go.nature.com/3NTD8R3
3
47
1
185
17,778
Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling go.nature.com/4hXER5O
38
2
174
62,792